Phase behavior of amorphous molecular dispersions - II: Role of hydrogen bonding in solid solubility and phase separation kinetics

被引:132
作者
Vasanthavada, M
Tong, WQ
Joshi, Y
Kislalioglu, MS [1 ]
机构
[1] Univ Rhode Isl, Dept Appl Pharmaceut Sci, Kingston, RI 02881 USA
[2] Novartis Pharmaceut, Pharmaceut & Analyt Dev, E Hanover, NJ 07936 USA
关键词
crystallization; hydrogen bonding; solid miscibility; solid solution; thermal analysis;
D O I
10.1007/s11095-004-1882-y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To determine the factors influencing "solid solubility" and phase separation kinetics of drugs from amorphous solid dispersions. Methods. Solid dispersions of griseofulvin-poly(vinyl pyrrolidone) (PVP) and indoprofen-PVP were prepared using solvent evaporation technique. Dispersions demonstrating single T-g were exposed to 40 degrees C/69% RH for 90 days. Drug solid solubility in the polymer and phase separation rates were determined from changes in T. of solid dispersions. FTIR spectroscopy and XRD were used to characterize drug-polymer interactions and drug crystallinity, respectively. Results. Freshly prepared solid dispersion of up to 30% w/w griseofulvin and indoprofen were molecularly miscible with PVP. Hydrogen bonding was evident in indoprofen-PVP, but not in griscofulvin-PVP dispersions. When exposed to 40 degrees C/69% RH, griseofulvin phase separated completely, whereas the solid solubility of indoprofen was determined as 13% w/w. The first-order rate constants of phase separation for 10%. 20%, and 30% w/w griseofulvin dispersions were estimated as 4.66, 5.19, and 12.50 (x10(2)) [day(-1)], and those of 20% and 30% w/w indoprofen dispersions were 0.62 and 1.25 (x10(2)) [day(-1)], respectively. Conclusions. Solid solubility of griseofulvin and indoprofen in PVP is -0% w/w and similar to 13% w/w, respectively. Drug-polymer hydrogen bonding in indoprofen-PVP dispersions favors solid solubility. Phase separation rate of drug from the solid dispersions depends on the initial drug content and the nature of drug-polymer interactions.
引用
收藏
页码:440 / 448
页数:9
相关论文
共 22 条
[1]   CRYSTALLIZATION MECHANISMS IN SOLUTION [J].
BOISTELLE, R ;
ASTIER, JP .
JOURNAL OF CRYSTAL GROWTH, 1988, 90 (1-3) :14-30
[2]  
BREITENBACH J, 1998, P CONTROL REL SOC, V25, P804
[3]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS - X-RAY-DIFFRACTION AND AQUEOUS SOLUBILITY STUDIES ON GRISEOFULVIN-POLYETHYLENE GLYCOL 6000 SYSTEMS [J].
CHIOU, WL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (07) :989-991
[4]   The mechanisms of drug release from solid dispersions in water-soluble polymers [J].
Craig, DQM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (02) :131-144
[5]   The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state [J].
Crowley, KJ ;
Zografi, G .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1417-1422
[6]   Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system [J].
Dannenfelser, RM ;
He, H ;
Joshi, Y ;
Bateman, S ;
Serajuddin, ATM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) :1165-1175
[7]   ACCELERATED STABILITY OF AN X-RAY AMORPHOUS FRUSEMIDE-POLYVINYLPYRROLIDONE SOLID DISPERSION [J].
DOHERTY, C ;
YORK, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (12) :1969-1987
[8]   Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers [J].
Forster, A ;
Hempenstall, J ;
Rades, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (03) :303-315
[9]   THE RELATIONSHIP BETWEEN THE GLASS-TRANSITION TEMPERATURE AND THE WATER-CONTENT OF AMORPHOUS PHARMACEUTICAL SOLIDS [J].
HANCOCK, BC ;
ZOGRAFI, G .
PHARMACEUTICAL RESEARCH, 1994, 11 (04) :471-477
[10]  
IMAIZUMI H, 1983, CHEM PHARM BULL, V31, P2510